• Publications
    Expected Returns Articles
  • Research
    Companies Funds Top 40 My Studies
  • Stock Screen
    New Stock Screen Manage Screens
  • Dashboards
    My Dashboards New Dashboard
  • Forum
  • Events
  • Search
  • Contact Us
  • Sign In

Johnson & Johnson (JNJ)

Company Ticker Sector | Industry Quality PAR
Johnson & Johnson JNJ Healthcare | Drug Manufacturers - General 97 9.0%
Current Price ( 5/26 4:00PM EDT) $154.35
CAPS Rating (Rate this stock on CAPS)
Expected Income Statement
Current Sales 96,263.0
Sales Growth Forecast 4.0%
Net Profit Margin 28.8%
Projected Shares Outstanding 2,554.25
EPS - Five year Forecast $13.20
Average P/E Ratio 16.0
Projected Average Price $211.23
Price Appreciation (Annualized) 6.5%
Annual Dividend Yield 2.5%
Projected Annual Return 9.0%
Quality
Financial Strength 100 24.9
EPS Stability 91 22.9
Industry Sales Growth Rate 4.0% 12.5
Industry Net Profit Margin 19.3% 18.7
Calculated Quality Rating 78.9
Fool CAPS

Total Players

13610 Outperforms
514 Underperforms
 

All-Stars (2591)

2529 Outperforms (98%)
62 Underperforms
 
Fundamental Data Updated: 05/12/2023
MIPAR 11.7%  
Sweet Spot 16.7% - 21.7%  
Top In Drug Manufacturers - General
Ticker Quality PAR
AMGN 99 10.5%
JNJ 97 9.0%
PFE 90 10.5%
SNY 91 10.0%
MRK 100 7.6%
Top In Healthcare
Ticker Quality PAR
INMD 89 22.1%
ENSG 96 17.3%
JAZZ 78 21.0%
CVS 86 18.9%
BAX 74 21.5%

© 2006 - 2023 Manifest Investing. All rights reserved.
About | Terms of Service | Disclaimer | Privacy Policy

Legend
Quality Legend:
Blue Excellent with quality greater than 80.
Green Good with quality between 60 and 80.
Neutral Average or below average with quality between 20 and 60.
Red Poor with quality less than 20.
Companies with less than 10 years of history are penalized by 5 points per year.
PAR Legend:
Green PAR is within the target range of MIPAR +5-10%, currently 5.1%-10.1%
Yellow PAR is above the target range of MIPAR +10%, currently 10.1%
PAR Projected Annual Return
MIPAR The Manifest Investing Median PAR of all stocks in the database.
Company Name Legend:
* Not covered by Value Line Standard Edition.
b Uses price-to-book value for valuation purposes.
P/CF Uses price-to-cash flow for valuation.